|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/517 | |||
| A61P 35/00 |
| (11) | Number of the document | 3089976 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15700325.2 |
| Date of filing the European patent application | 2015-01-02 | |
| (97) | Date of publication of the European application | 2016-11-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010013 |
| Date | 2015-01-02 |
| (87) | Number | WO 2015/103456 |
| Date | 2015-07-09 |
| (30) | Number | Date | Country code |
| 201461922982 P | 2014-01-02 | US | |
| 201461932317 P | 2014-01-28 | US | |
| 201462016155 P | 2014-06-24 | US |
| (72) |
TUSKAR, Mihaela, HR
RATKAJ, Marina, HR
ZEGARAC, Miroslav, HR
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | CRYSTALLINE FORMS OF AFATINIB DIMALEATE |
| CRYSTALLINE FORMS OF AFATINIB DIMALEATE |